A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design

Andrew Dauber, Ravi Savarirayan, Ricki Carroll, Moira Cheung, Valérie Cormier-Daire, Mohamad Maghnie, Noriyuki Namba, Oliver Semler, Sajda Ghani, Ian Sabir, Roberto Bassi · 2026

Read A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design by Andrew Dauber, Ravi Savarirayan, Ricki Carroll, Moira Cheung, Valérie Cormier-Daire, Mohamad Maghnie, Noriyuki Namba, Oliver Semler, Sajda Ghani, Ian Sabir, Roberto Bassi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13538998.txt.

Description

Andrew Dauber and co-authors published this trial design paper in 2026. It describes CANOPY HCH-3, a phase 3 study of vosoritide for children with hypochondroplasia, a genetic condition causing disproportionate short stature. The condition stems from an overactive growth-regulating gene, FGFR3, which brakes bone growth. Vosoritide counters that brake and is already approved for a related condition, achondroplasia. An earlier smaller trial found a year of the drug raised growth in these children and was well tolerated.

The new study enrolls children from age three to under eighteen with confirmed diagnoses and prior height records. They are assigned at random to daily vosoritide or placebo for 52 weeks, followed by a short safety watch. The main measure is the change in yearly growth speed against placebo. The authors say the trial will firm up the evidence for the first treatment aimed at the condition's root signaling.

Catalog record

CREATORAndrew Dauber, Ravi Savarirayan, Ricki Carroll, Moira Cheung, Valérie Cormier-Daire, Mohamad Maghnie, Noriyuki Namba, Oliver Semler, Sajda Ghani, Ian Sabir, Roberto Bassi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13538998

Browse the full library · About the Tower of Babel